Medically reviewed by Larysa Grevtsova, MD
MEDVi vs TrimRx: Which Is Right for You?
MEDVi and TrimRx are both large-scale, cash-pay compounded GLP-1 telehealth platforms with tens of thousands of patients and asynchronous (no mandatory video visit) intake models. Their core offerings look similar on the surface, but their pricing philosophy and format options differ in ways that matter depending on what you’re optimizing for.
Medications and Formats
MEDVi offers compounded semaglutide and tirzepatide in both injectable and oral dissolving tablet formats — a genuinely rare combination, since most telehealth platforms offer only injections or, less commonly, only one oral option. MEDVi also offers brand-name Ozempic for patients who specifically want an FDA-approved product, though at a substantially higher price than its compounded options.
TrimRx also offers both injectable and oral formats, including a distinct oral GLP-1/GIP combination option, plus brand-name medications available through the platform for patients willing to pay full retail pricing. Between the two, MEDVi and TrimRx offer a broadly similar range of formats, so format alone isn’t likely to be the deciding factor between them — pricing structure is where they diverge more clearly.
Pricing Structure
This is the most important practical difference to understand.
MEDVi advertises a low first-month price for compounded semaglutide (commonly cited around $179) that increases to a higher ongoing monthly rate afterward (commonly cited around $299) — a promotional-to-standard pricing jump that’s worth budgeting for beyond the headline number. Tirzepatide pricing has been reported inconsistently across sources, generally landing higher than semaglutide.
TrimRx markets what it calls “Guaranteed Pricing” — a flat monthly rate that doesn’t increase as your dose escalates, which is a genuine point of differentiation in a market where many competitors quietly raise prices once you reach a therapeutic maintenance dose. Reported pricing for TrimRx has generally sat around $199/month for compounded semaglutide and $349/month for compounded tirzepatide, with multi-month prepay plans lowering the effective monthly rate somewhat. TrimRx’s all-inclusive price is generally described as covering the medication, injection supplies (syringes, alcohol pads), consultation, and shipping.
In practice, this means MEDVi may look cheaper in month one, but TrimRx’s flat-rate structure can end up more predictable — and potentially cheaper — over a longer treatment period once you’re past the introductory window and at a stable maintenance dose. Getting a specific quote for your expected maintenance dose from both, rather than comparing headline first-month prices, is the more reliable way to compare them.
Clinical Visit Model
Both platforms generally operate on an asynchronous review model rather than requiring a mandatory live video visit for most patients — intake questionnaire, licensed clinician review (commonly within 24–48 hours), and prescription if approved, with video visits required in some cases depending on state law or individual health history rather than as a blanket requirement.
Support and Reported Issues
MEDVi advertises 24/7 clinician access and unlimited messaging, along with free lab work through Quest Diagnostics when medically necessary. Independent reviews note that billing and refund handling is the most consistently reported complaint category, along with a 2026 FDA warning letter the company has attributed to marketing language used by an affiliate rather than MEDVi’s own site.
TrimRx similarly advertises 24/7 provider portal access. Independent reviews note billing confusion as the most common source of negative feedback (reported as a notable share of critical Trustpilot reviews), rather than complaints about medication quality or clinical care itself.
In both cases, the recurring theme across independent reviews is that billing and cancellation clarity — not medication safety or clinical oversight — is where patients report the most friction. Reading the specific cancellation and refund terms before your first charge is a reasonable precaution with either provider.
Bottom Line
MEDVi and TrimRx both offer a broad range of compounded GLP-1 formats through an asynchronous, cash-pay model, but their pricing philosophies differ: MEDVi leads with a lower introductory price that rises after month one, while TrimRx emphasizes a flat rate that doesn’t increase as you titrate to a higher dose. If minimizing your very first invoice matters most, MEDVi’s promotional pricing may look more appealing; if you want price predictability over a longer treatment course, TrimRx’s flat-rate model is built around that specifically. Either way, request an itemized quote for your expected maintenance dose, and review the cancellation policy in writing before your first payment, since billing clarity is the area where both companies’ patient reviews most consistently raise concerns.
For a side-by-side view of these two providers alongside the rest of the market, see our comparison table.